Whats Hot Today : Baidu Inc (ADR) (NASDAQ:BIDU), Conversant, Inc. (NASDAQ:CNVR), Tenet Healthcare Corp. (NYSE:THC), Uroplasty, Inc. (NASDAQ:UPI), AbbVie Inc. (NYSE:ABBV),

German luxury carmaker BMW is teaming up with Chinese internet giant Baidu Inc (ADR) (NASDAQ:BIDU) to start highly automated driving trials in Beijing and Shanghai. Baidu Inc (ADR) (NASDAQ:BIDU) belongs to Technology sector. Its net profit margin is 29.70% and weekly performance is 1.60%. On last trading day company shares ended up $218.23. Baidu Inc (ADR) (NASDAQ:BIDU) distance from 50-day simple moving average (SMA50) is 0.38%.

On Sept.15, The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Conversant, Inc. (NASDAQ:CNVR) in connection with the sale of the Company to Alliance Data Systems Corporation. Conversant, Inc. (NASDAQ:CNVR) shares moved down -0.55% in last trading session and ended the day at $34.25. CNVR Gross Margin is 67.40% and its return on assets is 17.50%. Conversant, Inc. (NASDAQ:CNVR) quarterly performance is 35.32%.

Tenet Healthcare Corp (NYSE:THC) has been given a “B” credit rating by Morningstar. The firm’s “B” rating indicates that the company is a high default risk. They also gave their stock a two star rating. On 30 September, Tenet Healthcare Corp. (NYSE:THC) shares moved down -2.06% and was closed at $59.39. THC EPS growth in last 5 year was -32.10%. Tenet Healthcare Corp. (NYSE:THC) year to date (YTD) performance is 41.00%.

Zacks upgraded shares of Uroplasty (NYSE:UPI) from an underperform rating to a neutral rating in a research note released on Monday morning. They currently have $2.60 target price on the stock. Uroplasty, Inc. (NASDAQ:UPI) ended the last trading day at $2.50. Company weekly volatility is calculated as 4.31% and price to cash ratio as 5.20. Uroplasty, Inc. (NASDAQ:UPI) showed a weekly performance of -1.57%.

Seeking to dissuade any doubters, AbbVie Inc. (NYSE:ABBV) chief executive Richard Gonzalez started the week by sending a memo to Shire employees to say that plans are proceeding apace to acquire Shire. At the same time, Chris Turek, a vp of enterprise strategies at AbbVie, sent a memo to AbbVie employees in which he talked up “similar cultures” and predicted the $54 billion deal would close in the fourth quarter. AbbVie Inc. (NYSE:ABBV) shares moved down -1.30% in last trading session and ended the day at $57.76. ABBV Gross Margin is 76.40% and its return on assets is 14.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 2.30%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone